Chris joined GTCR in 2013. Prior to joining GTCR, he worked as an Investment Banking Analyst in the Mergers & Acquisitions / Corporate Finance group of Morgan Stanley. Chris graduated cum laude from the University of Notre Dame with a BBA in finance.
Chris is currently a Director of Riverchase Dermatology and works closely with TerSera Therapeutics, Cedar Gate Technologies and Ceba-Tech. He was previously involved in past GTCR investments Cole-Parmer, Crealta Pharmaceuticals and Curo.
University of Notre Dame